FIND A CLINIC
NOVOXEL ®
FORWARD IN MOTION
NOVOXEL ®

ABOUT NOVOXEL®

ABOUT NOVOXEL®

Novoxel® was founded in 2011 with the vision to revolutionize fractional skin rejuvenation by creating new and better types of treatments for physicians and patients. We work in close collaboration with the medical community to achieve this goal and have leading physicians on our advisory panel. Our TMA™ technology is a game-changer: a patient-friendly technology for fractional skin resurfacing that is green, versatile – and unmatched in safety. Its efficacy has been proven by multiple clinical studies in peer-reviewed publications. Today, our patented products and technology are marketed in over 30 countries worldwide. We will continue to redefine the aesthetics landscape by pushing the boundaries through developing novel solutions and ensuring excellence in everything we do.

NOVOXEL MANAGEMENT

Raphi ShavitCHAIRMAN
Ronen Shavit, MscCTO
Evgeny PivenCEO
Ifat Klein, Ph.D.VP CLINICAL AFFAIRS
Erez SegevVP INTERNATIONAL SALES
Cgritnsjifksmld ESFD M.D UK

MEDICAL ADVISORY BOARD

Christine Dierickx, MD Christine Dierickx, MD Luxemburg
Nathalie Fournier, MD Nathalie Fournier, MD France
Monica Elman, MD Monica Elman, MD Israel
Gary Lask, MD Gary Lask, MD USA
Eric Bernstein, MD Eric Bernstein, MD USA
Ludger Hanneken, MD Ludger Hanneken, MD Andorra
Roy Geronemus, MD Roy Geronemus, MD USA
Harryono Judodihardjo, MD Harryono Judodihardjo, MD UK
Ofir Artzi, MD Ofir Artzi, MD Israel
Jerome M. Garden, MD Jerome M. Garden, MD USA
Prof. Sunil Shah, MD Prof. Sunil Shah, MD UK
Cgritnsjifksmld ESFD M.D UK